文章詳目資料

中西整合醫學雜誌

  • 加入收藏
  • 下載文章
篇名 Combined Acupuncture, Steroid and Hyperbaric Oxygen Therapy in Sudden Deafness--A Clinical Experience of 35 Cases
卷期 11:1
並列篇名 以針灸類固醇及高壓氧合併治療突發性耳聾35例經驗報告
作者 李長光李惠傑張陸澎盧思田黃玉龍
頁次 017-025
關鍵字 突發性耳聾針灸高壓氧Sudden deafnessAcupunctureHyperbaric oxygen
出刊日期 200906

中文摘要

突發性耳聾之原因可能是病毒感染、血管阻塞或耳膜破裂等。目前治療之方法有類固醇、血管擴張劑、血液稀釋、星狀交感神經節阻斷、及高壓氧治療。文獻顯示針灸治療突發性耳聾亦有效,爲加強突發性耳聾之療效,我們嘗試使用以針灸、類固醇及高壓氧之合併方法來治療35例突發性耳聾並比較其治療前後純音聽力之變化。從1998年6月至2006年12月間,我們收集35例突發性耳聾,14例女性21例男性其平均年齡45.5歲(15-86歲),其中6例有糖尿病、高血壓或腦中風病史。所有病患皆接受針灸、類固醇及高壓氧之合併療法。針灸使用傳統之頭部及手部穴位,類固醇1mg/kg/day給7天,高壓氣使用多人高壓艙50呎/120分鐘,1次/天,5天/週,平均治療8次。合併療法之前後實施純音聽力測試並比較平均聽力喪失之變化。結果35例突發性耳聾其中30例(85.7%)顯示平均聽力喪失由治療前之75.9±24.9dB改善至治療後之53.9±32.2dB,P<0.01。35例中有19例(54.3%)其平均聽力喪失明顯改善(≧20dB)。有5例其發病至治療期間≧3星期,平均聽力喪失之改善僅有2.3dB,而有8例發病至治療期間≧1星期且<3星期及有22例發病至治療期間<1星期,其平均聽力喪失之改善分別爲25.1dB及25.3dB。經由合併療法之治療結果我們認爲針灸、類固醇及高壓氧之合併療法對於突發性耳聾可能是一種有用之治療選擇。早期治療(發病至治療期間<3星期)似乎有較好之臨床療效。

英文摘要

Current treatments for sudden deafness (SD) include steroid, vasodilator, hemodilution, stellate ganglion block, and hyperbaric oxygen (HBO2) therapy. Two reports showed the acupuncture treatment was also effective for SD. In order to strengthen the therapeutic efficiency of SD, we used a combined treatment of acupuncture, steroid, and HBO2 in 35 eases and compared the extent of hearing loss before and after the combined treatment. Between June 1998 and December 2006, 35 cases of SD were collected in this retrospective study and all received a combined treatment of acupuncture, steroid and HBO2. The acupuncture treatment was carried out at the traditional acupuncture points over head and hand. The steroid therapy was given with oral prednisolone at a dosage of 1mg/kg/day for 7 days. The HBO2 therapy was conducted at 2.5 ATA of 100% oxygen, 120 minutes for an average of 8 sessions in our multi-place hyperbaric chamber. Before & after the combined treatment, the pure tone audiogram was taken to evaluate the extent of hearing loss. After the combined treatment, 30 of 35 cases (85.7%) showed an improvement in hearing loss from 75.9±24.9 dB (before) to 53.9±32.2 dB (after), p<0.01. Nineteen of 35 cases (54.3%) had marked improvement in hearing loss (≧20 dB). In five cases with the period from onset to treatment for those ≧3 weeks, there were only an improvement for an average of 2.36 dB in hearing loss as compared to 25.1 dB for those ≧1 week and <3 weeks (n=8), and 25.3 dB for those <1 week (n=22). From these results, we suggest that this combined treatment of acupuncture, steroid and HBO2 may be a useful management for SD. The early treatment for those periods <3 weeks from onset of SD seems to have a better clinical outcome.

相關文獻